Cardiff Oncology, Inc. (CRDF)

Cardiff Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	102	66	63	238	635	10
Market Cap Growth	223.64%	5.71%	-73.69%	-62.59%	6519.33%	-20.54%
Enterprise Value	35	-7	-40	100	505	1
PE Ratio	-	-1.59	-1.61	-8.39	-28.12	-0.57
PS Ratio	164.97	135.50	162.04	662.14	1736.31	39.24
PB Ratio	1.65	0.95	0.59	1.69	4.96	1.31
P/FCF Ratio	-7.79	-2.10	-1.80	-10.23	-38.45	-0.72
P/OCF Ratio	-7.96	-2.14	-1.85	-10.32	-38.95	-0.72
EV/Sales Ratio	58.10	-13.43	-103.64	278.57	1380.81	4.63
EV/EBITDA Ratio	-4.35	0.16	1.04	-3.59	-26.83	-0.07
EV/EBIT Ratio	-4.31	0.16	1.03	-3.53	-26.18	-0.07
EV/FCF Ratio	-5.66	0.21	1.15	-4.30	-30.58	-0.08
Debt / Equity Ratio	0.03	0.03	0.03	0.02	0.01	0.24
Debt / EBITDA Ratio	-0.05	-0.05	-0.07	-0.11	-0.05	-0.11
Debt / FCF Ratio	-0.07	-0.07	-0.08	-0.13	-0.05	-0.13
Quick Ratio	5.71	7.19	13.58	21.55	21.46	1.97
Current Ratio	5.91	7.42	14.25	22.28	21.79	2.37
Asset Turnover	0.01	0.01	0.00	0.00	0.01	0.02
Interest Coverage	-	-	-	-	-9652.50	-
Return on Equity (ROE)	-54.60%	-50.20%	-33.00%	-21.10%	-47.00%	-205.60%
Return on Assets (ROA)	-47.10%	-44.30%	-30.40%	-20.10%	-41.80%	-125.10%
Return on Capital (ROIC)	-70.43%	-63.17%	-36.59%	-20.10%	-14.79%	-184.52%
Earnings Yield	-40.00%	-62.71%	-61.92%	-11.91%	-3.56%	-174.02%
FCF Yield	-30.43%	-47.59%	-55.68%	-9.78%	-2.60%	-138.90%
Buyback Yield / Dilution	-0.00%	-2.47%	-11.71%	-86.97%	-249.44%	-156.37%
Total Shareholder Return	-0.00%	-2.47%	-11.71%	-86.97%	-249.44%	-156.37%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).